[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363604-105":59,"doc-detail-363604-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","1h-nmr-based-serum-metabolomics-identifies-discriminatory-metabolic-signatures-associated-with-pancreatic-cancer","1H NMR-based serum metabolomics identifies discriminatory metabolic signatures associated with pancreatic cancer","","Pancreatic cancer remains a highly aggressive malignancy with late detection and poor prognosis, making reliable early biomarkers essential. A proton nuclear magnetic resonance (1H-NMR) serum metabolomics workflow compared pancreatic cancer patients with matched healthy controls, profiling circulating metabolites and applying PCA/PLS-DA for group discrimination. ROC analyses assessed diagnostic performance of key metabolites, while pathway enrichment clarified cancer-related metabolic alterations. Distinct metabolite composition differences, diagnostic candidates, and metabolic pathway shifts support non-invasive biomarker development.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/1h-nmr-based-serum-metabolomics-identifies-discriminatory-metabolic-signatures-associated-with-pancreatic-cancer/363604/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/1h-nmr-based-serum-metabolomics-identifies-discriminatory-metabolic-signatures-associated-with-pancreatic-cancer/363604.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does 1H-NMR serum metabolomics differentiate pancreatic cancer patients from healthy controls?","Question",{"text":113,"@type":114},"Serum metabolic profiles are generated by 1H-NMR spectroscopy and then analyzed with multivariate statistics such as PCA and PLS-DA to separate pancreatic cancer and healthy control groups based on distinct metabolite patterns.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which statistical methods were used to assess diagnostic discrimination?",{"text":118,"@type":114},"PCA and PLS-DA were used for multivariate discrimination, and receiver operating characteristic (ROC) curve analysis evaluated the diagnostic potential of selected metabolites.",{"name":120,"@type":111,"acceptedAnswer":121},"What metabolic changes were reported in pancreatic cancer compared with healthy controls?",{"text":122,"@type":114},"Amino acids were reported as significantly reduced in the pancreatic cancer group, while carbohydrate metabolites such as glucose and lactate were elevated, consistent with enhanced glycolytic activity and pathway-level metabolic shifts.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363604,1790190354,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398046744996,"[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \n1 H NMR-based serum metabolomics identifies discriminatory metabolic signatures associated with pancreatic cancer  \nSudhir Kumar Shekhar1,2, Umesh Kumar2, Ashish Gupta2, Abhai Verma3, Gaurav Pandey4􀀍 & Dilutpal Sharma1􀀍  \nPancreatic cancer (PC) remains one of the most aggressive malignancies, characterized by late-stage diagnosis and poor prognosis. Identifying reliable biomarkers for early detection is crucial to improving survival outcomes. This study utilizes proton nuclear magnetic resonance ( 1H-NMR) metabolomics to analyze serum metabolic profiles and identify potential biomarkers differentiating PC patients from healthy controls (HC) . Serum samples were collected from PC patients and matched HC individuals.  \n1H-NMR spectroscopy was employed to profile circulatory metabolites. Multivariate statistical analyses, including Principal Component Analysis (PCA) and Partial Least Squares Discriminates Analysis (PLS-DA), were conducted to distinguish between PC and HC groups. Receiver Operating Characteristic (ROC) curve analysis was performed to evaluate the diagnostic potential of key metabolites. Pathway enrichment analysis further elucidated the metabolic alterations associated with PC progression. The metabolomic profiling revealed distinct differences in metabolite composition between PC and HC groups. Amino acids, crucial for cellular metabolism and protein synthesis, were significantly reduced in the PC group (12.02%) compared to the HC group (18.43%). Conversely, carbohydrate metabolites, including glucose and lactate, were elevated in PC (56.92%) relative to HC (47.38%), indicating enhanced glycolytic activity. PCA and PLS-DA analyses confirmed clear metabolic separation between groups (PERMANOVA p = 0.001, PLS-DA R2 = 0.87, Q2 = 0.73) . Key metabolites differentiating PC from HC included methanol, glycine, and lactate for PC, and valine, alanine, and methylhistidine for HC. ROC analysis identified alanine (AUC = 0.96), isoleucine (AUC = 0.92), and valine (AUC = 0.93) as potential diagnostic biomarkers. Pathway analysis revealed significant alterations in amino acid metabolism, notably the alanine, aspartate, and glutamate metabolism pathway. This study demonstrates the utility of 1H-NMR-based serum metabolomics in distinguishing PC from  \nHC and identifies potential biomarkers for metabolic alterations associated with PC. The findings underscore the critical role of metabolic reprogramming in PC and offer promising avenues for developing non-invasive diagnostic tools. Further validation in larger cohorts is warranted to confirm the diagnostic potential of the identified biomarkers.  \nKeywords 1H NMR metabolomics, Pancreatic cancer, Serum biomarker, Multivariate analysis and early detetion  \nPancreatic cancer (PC) is recognized as one of the most aggressive and lethal malignancies worldwide, characterized by a dismal prognosis and a five-year survival rate of less than 5%1. Although PC accounts for only about 2% of all cancer diagnoses, it is the fourth leading cause of cancer-related deaths globally. This high  \n1Department of Biochemistry, King George Medical University Lucknow, Lucknow, UP 226003, India. 2Centre of Biomedical Research, SGPGIMS Campus, Lucknow, UP 226014, India. 3Department of Gastroenterology-Medanta Hospital, Lucknow, UP 226002, India. 4Department of Gastroenterology-SGPGIMS, Lucknow, UP 226014, India.  \n􀀍 email: [drgauravpandey@yahoo.com](drgauravpandey@yahoo.com); [dilutpal@kgmcindia.edu](dilutpal@kgmcindia.edu)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nmortality rate is primarily due to the asymptomatic nature of the disease in its early stages and the lack of effective early diagnostic tools2,3.  \nIn India, the incidence of PC remains relatively low, ranging from 0.5–2.4 per 100,000 men and 0.2–1.8 per 100,000 women, with slightly higher rates observed in the urban male populatio","cbCailT7pPbg8y64","https://ap.wps.com/l/cbCailT7pPbg8y64","pdf",2714536,14,"English","# Study rationale and clinical need\n## Current diagnostic limitations and importance of early detection\n## Metabolomics and 1H-NMR approach\n# Analytical workflow\n## Serum collection and metabolite profiling\n## Multivariate statistics and separation of groups\n## ROC evaluation of diagnostic biomarkers\n## Pathway enrichment analysis\n# Key findings\n## Differential metabolite patterns between groups\n## Candidate biomarkers and diagnostic performance","[{\"question\":\"How does 1H-NMR serum metabolomics differentiate pancreatic cancer patients from healthy controls?\",\"answer\":\"Serum metabolic profiles are generated by 1H-NMR spectroscopy and then analyzed with multivariate statistics such as PCA and PLS-DA to separate pancreatic cancer and healthy control groups based on distinct metabolite patterns.\"},{\"question\":\"Which statistical methods were used to assess diagnostic discrimination?\",\"answer\":\"PCA and PLS-DA were used for multivariate discrimination, and receiver operating characteristic (ROC) curve analysis evaluated the diagnostic potential of selected metabolites.\"},{\"question\":\"What metabolic changes were reported in pancreatic cancer compared with healthy controls?\",\"answer\":\"Amino acids were reported as significantly reduced in the pancreatic cancer group, while carbohydrate metabolites such as glucose and lactate were elevated, consistent with enhanced glycolytic activity and pathway-level metabolic shifts.\"}]","1H NMR-based serum metabolomics identifies discriminatory metabolic signatures associated with pancreatic cancer | PDF",1790152077,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2ac4dcffc6b9a83ba22886bd61564db.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fd6be14b3b258abdcc429a3f73340a1.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b11ad27811d5fce6c811e8cc1092d604.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dbe9ebeb3c8494a90220cb512e7b903.webp",980,1287]